Results 41 to 50 of about 110,621 (200)
Pharmaceutics, 2019 Porphyrins are known therapeutic agents for photodynamic therapy of cancer and also imaging agents for NIR fluorescence imaging, MRI, or PET. A combination of interesting features makes tetrapyrrolic macrocycles suitable for use as theranostic agents ...
Bruno F. O. Nascimento +4 more
doaj +1 more source
Prostate Cancer—PET Imaging Update
, 2023 Prostate cancer is the most common non-dermatologic cancer in men, and one of the leading causes of cancer-related mortality. The incidence of prostate cancer increases precipitously after the age of 65 and demonstrates variable aggressiveness, depending
Gupta, Akshya +11 more
core +1 more source
Metal-Based Complexes as Pharmaceuticals for Molecular Imaging of the Liver
Pharmaceuticals, 2019 This article reviews the use of metal complexes as contrast agents (CA) and radiopharmaceuticals for the anatomical and functional imaging of the liver.
Julia Greiser +2 more
doaj +1 more source
Development of a 68Ga-Fluorinated Porphyrin Complex as a Possible PET Imaging Agent [PDF]
Nuclear Medicine and Molecular Imaging, 2011 Due to the interesting pharmacologic properties of porphyrins, the idea of developing a possible tumor imaging agent using PET by incorporating (68)Ga into a suitable porphyrin ligand was investigated.(68)Ga-labeled 5,10,15,20-tetrakis(pentafluoro-13 phenyl) porphyrin ((68)Ga-TFPP) was prepared using freshly eluted [(68)Ga]GaCl3 obtained from a 68Ge ...
Yousef, Fazaeli +7 more
openaire +2 more sources
Artificial tissue binding models : development and comparative evaluation of high - throughput lipophilicity assays and their use for PET tracer optimization [PDF]
, 2015 The purpose of this thesis was to increase the efficiency of the Positron Emission Tomography (PET) tracer development process. Since many neuroimaging agents fail due to undesirably high non-specific binding (NSB) to brain tissue, we aimed at estimating
Assmus, Frauke
core +1 more source
Update on the Use of PET/MRI Contrast Agents and Tracers in Brain Oncology: A Systematic Review
International Journal of Nanomedicine, 2022 Alessio Smeraldo,1– 3,* Alfonso Maria Ponsiglione,1,* Andrea Soricelli,4 Paolo Antonio Netti,1– 3 Enza Torino1– 3 1Department of Chemical, Materials and Production Engineering, University of Naples “Federico II”, Naples, 80125, Italy ...
Smeraldo A +4 more
doaj
Amyloid tracers detect multple binding sites in Alzheimer´s disease brain tissue. [PDF]
, 2013 Imaging fibrillar amyloid-β deposition in the human brain in vivo by positron emission tomography has improved our understanding of the time course of amyloid-β pathology in Alzheimer’s disease. The most widely used amyloid-β imaging tracer so far is 11C-
Nordberg, A, +9 more
core +1 more source
Radiolabeled Iron Oxide Nanoparticles as Dual Modality Contrast Agents in SPECT/MRI and PET/MRI
Nanomaterials, 2023 During the last decades, the utilization of imaging modalities such as single photon emission computed tomography (SPECT), positron emission tomography (PET), and magnetic resonance imaging (MRI) in every day clinical practice has enabled clinicians to ...
Maria-Argyro Karageorgou +3 more
doaj +1 more source
EJNMMI Research, 2021 Background Animal brain functions evaluated by in vivo imaging under anesthesia can be affected by anesthetic agents, resulting in incorrect assessment of physiological brain function.
Chie Suzuki +2 more
doaj +1 more source
Review article liver metastases
Journal of the Belgian Society of Radiology, 2011 Liver metastases are a very common site of distant metastases. Detection and accurate characterization of liver metastases is of importance to guide therapy.
W Schima +3 more
doaj +1 more source